Course Outline
Click on the links below to preview selected pages from this course.
- Myeloproliferative Neoplasms
- Chronic Myeloid Leukemia
- Chronic Neutrophilic Leukemia
- Hypereosinophilic Syndrome/Chronic Eosinophilic Leukemia
- Hypereosinophilic Syndrome (HES)
- Chronic Eosinophilic Leukemia (CEL)
- What causes the characteristic heart and/or lung damage frequently demonstrated in patients with chronic eosinophilic leukemia?
- Essential Thrombocythemia
- Essential Thrombocythemia (ET)
- Diagnosis of Essential Thrombocythemia (ET)
- Diagnosis of Essential Thrombocytosis (ET): Bone Marrow Findings
- Essential Thrombocytosis (ET) Diagnosis
- ET Treatment
- Which of the following thrombocytic characteristics are often associated with essential thrombocytosis (ET)?
- Primary Myelofibrosis
- Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis: World Health Organization (WHO) Criteria
- Which of the following red blood cell morphologic features is associated with primary myelofibrosis?
- Polycythemia Vera
- Polycythemia Vera (PV)
- Diagnosis of Polycythemia Vera (PV)
- Treatment of Polycythemia Vera
- Which type of anemia can be caused by the common treatment for polycythemia vera, which is used to manage patient symptoms?
- Myeloproliferative Neoplasm, Unclassifiable (MPN-u)
- Myeloproliferative Neoplasms, Unclassifiable (MPD-u)
- Summary
- Table: Laboratory Findings Associated with Myeloproliferative Neoplasms (MPNs)
- References
Additional Information
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
Author information: Leah Coppolino, MPH, CLS(NCA), MT(ASCP) is the Director of Education and Outreach in the Department of Pathology and Laboratory Medicine at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.
Reviewer information: Rebecca J. Laudicina, PhD, MLS(ASCP)CM is Professor Emeritus in the Division of Clinical Laboratory Science at The University of North Carolina at Chapel Hill’s School of Medicine. She obtained a Master of Education and PhD in Educational Psychology from Temple University. She is the author of numerous hematology-related publications.
Reviewer information: Rory Huschka, M. Ed., MT(ASCP), has over 20 years of experience as a medical technologist, technical supervisor, professor, and manager. He is the former Director of Clinical Laboratory Science and Medical Laboratory Technician Programs at Brookline College. He is currently a Program Director at MediaLab, Inc. Rory holds a BS degree in Medical Technology from North Dakota State University and a Masters in Educational Leadership from Argosy University. He has also completed the Six Sigma Green Belt training at Villanova University.